Netrin-1 expression analysis in human endometrial carcinomas

Exploratory Score: 0.800 Price: $0.50 endometrial carcinoma human endometrial carcinoma tissue samples Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting NTN1 in human endometrial carcinoma tissue samples. Primary outcome: netrin-1 expression levels

Description

Investigation of netrin-1 upregulation in human endometrial carcinoma samples. The study examined netrin-1 expression levels across a majority of human endometrial carcinoma specimens to establish the prevalence of netrin-1 overexpression in this cancer type. This foundational analysis provided the rationale for targeting netrin-1 as a therapeutic approach in endometrial cancer, demonstrating that netrin-1 serves as a pro-tumoral mechanism in these cancers.

TARGET GENE
MODEL SYSTEM
human endometrial carcinoma tissue samples
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
Netrin-1 signaling pathway
SOURCE
extracted_from_pmid_37532934
PRIMARY OUTCOME
netrin-1 expression levels

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

📖 Wiki Pages

NTN1 Gene - Netrin 1geneCancerdiseaseProtein Aggregation SeedingmechanismNetrin Signaling Pathway in NeurodegenerationmechanismPD Therapeutic Approaches ScorecardtherapeuticAxon Guidance in 4R-TauopathiesmechanismSeptal Nuclei Neuronscell

Protocol

Expression analysis of netrin-1 in human endometrial carcinoma specimens

Expected Outcomes

Upregulation of netrin-1 in majority of endometrial carcinomas

Success Criteria

Demonstration of netrin-1 overexpression in endometrial cancer samples

Related Hypotheses (1)

Netrin-1 Gradient Restoration0.327

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.